Commercial viability is driving the research agenda in too many cases. Not what’s medically necessary and what’s medically useful.
In 1980, the government started allowing patents on living organisms such as pathogens. Perfect timing for scientists to make a mad dash for parts of newly-discovered Lyme and keep the information locked away to protect future profits.
These so-called experts continue to research Lyme disease with federal funds, then start private firms and obtain patents. They write guidelines for insurance companies and HMOs so that the disease doesn’t exist (yet) or require coverage. Not only do Lyme victims spend hundreds of thousands for medical treatment, but they can’t be covered for Lyme! (more…)